Barchart.com
[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.
Menu

Collplant Biotechnologies Ltd ADR (CLGN)

Collplant Biotechnologies Ltd ADR (CLGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
CollPlant Issues Letter to Shareholders PR Newswire - Mon Apr 13, 6:00AM CDT

REHOVOT, Israel , April 13, 2026 /PRNewswire/ -- CollPlant  (NASDAQ: CLGN), a regenerative and aesthetic medicine company developing innovative technologies and products based on its...

CLGN : 0.3725 (-4.51%)
COLLPLANT BIOTECHNOLOGIES REPORTS 2025 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE PR Newswire - Thu Mar 26, 7:30AM CDT

REHOVOT, Israel , March 26, 2026 /PRNewswire/ -- CollPlant Biotechnologies (Nasdaq: CLGN), a regenerative and aesthetics medicine company developing innovative technologies and products based on...

CLGN : 0.3725 (-4.51%)
CollPlant Biotechnologies Receives Nasdaq Notification Regarding Minimum Bid Requirement PR Newswire - Tue Mar 24, 3:01PM CDT

REHOVOT, Israel , March 24, 2026 /PRNewswire/ -- CollPlant Biotechnologies (Nasdaq: CLGN), a regenerative and aesthetic medicine company developing innovative technologies and products based on its...

CLGN : 0.3725 (-4.51%)
CollPlant Biotechnologies Launches Redesigned Corporate Website PR Newswire - Wed Mar 18, 8:00AM CDT

REHOVOT, Israel , March 18, 2026 /PRNewswire/ -- CollPlant (Nasdaq: CLGN), a regenerative and aesthetic medicine company developing innovative technologies and products based on its proprietary...

CLGN : 0.3725 (-4.51%)
COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR FULL YEAR 2025 FINANCIAL RESULTS PR Newswire - Wed Mar 11, 7:00AM CDT

REHOVOT, Israel , March 11, 2026 /PRNewswire/ -- CollPlant Biotechnologies (Nasdaq: CLGN), a regenerative and aesthetics medicine company developing innovative technologies and products based...

CLGN : 0.3725 (-4.51%)
CollPlant Biotechnologies Announces Korean Patent Allowance Secured for its Photocurable Dermal Filler PR Newswire - Thu Feb 26, 7:00AM CST

REHOVOT, Israel , Feb. 26, 2026 /PRNewswire/ -- CollPlant Biotechnologies (Nasdaq: CLGN), a regenerative and aesthetic medicine company developing innovative technologies and products based on...

CLGN : 0.3725 (-4.51%)
CollPlant Elevates rhCollagen 3D Bioprinting Portfolio with Launch of Ready-to-Print BioFlex PR Newswire - Mon Feb 23, 6:00AM CST

REHOVOT, Israel , Feb. 23, 2026 /PRNewswire/ -- CollPlant (NASDAQ: CLGN), a regenerative and aesthetic medicine company developing innovative technologies and products based on its proprietary...

CLGN : 0.3725 (-4.51%)
CollPlant Targets New Aesthetic Market Driven by GLP-1 Weight-Loss Treatments PR Newswire - Tue Feb 17, 6:00AM CST

Next-generation rhCollagen-based technology aims to restore facial structure and skin quality in patients experiencing volume depletion linked to GLP-1 weight-loss therapies

CLGN : 0.3725 (-4.51%)
COLLPLANT BIOTECHNOLOGIES ANNOUNCES $2.0 MILLION REGISTERED DIRECT OFFERING PR Newswire - Thu Feb 5, 7:00AM CST

REHOVOT, Israel , Feb. 5, 2026 /PRNewswire/ -- CollPlant Biotechnologies (NASDAQ: CLGN), a regenerative and aesthetics medicine company developing innovative technologies and products based on its...

CLGN : 0.3725 (-4.51%)
COLLPLANT BIOTECHNOLOGIES REPORTS 2025 THIRD QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE PR Newswire - Wed Nov 26, 2025

REHOVOT, Israel , Nov. 26, 2025 /PRNewswire/ -- CollPlant Biotechnologies (Nasdaq: CLGN), a regenerative and aesthetics medicine company developing innovative technologies and products based on its...

CLGN : 0.3725 (-4.51%)

Barchart Exclusives

Silver Prices Have Pulled Back, But Bank of America Predicts They Could Soar to $309 Before the End of 2026. How? Barchart - 19 minutes ago
Bank of America’s $309 silver call is really an upper‑bound scenario built on the gold‑to‑silver ratio snapping back to rare historical extremes, not a central forecast. Getting there would require tight supply, surging industrial and safe‑haven demand, and a dramatic ratio squeeze all at once. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.